TW200934458A - Polymerizable water-soluble or alcohol-soluble UV-light absorbent - Google Patents
Polymerizable water-soluble or alcohol-soluble UV-light absorbent Download PDFInfo
- Publication number
- TW200934458A TW200934458A TW97104292A TW97104292A TW200934458A TW 200934458 A TW200934458 A TW 200934458A TW 97104292 A TW97104292 A TW 97104292A TW 97104292 A TW97104292 A TW 97104292A TW 200934458 A TW200934458 A TW 200934458A
- Authority
- TW
- Taiwan
- Prior art keywords
- compound
- hydrogen
- formula
- soluble
- ultraviolet light
- Prior art date
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
200934458 九、發明說明: 【發明所屬之技術領域】 5 10 15 ❹ 20 本發明係關於一種新穎的可聚合型水溶性或醇溶性紫 外光吸收劑’本發明並揭露該新穎化學品其製造方法及其 在光學醫藥材料上的應用。 【先前技術】 曰光中之紫外線大部分係以波長介於290 nm〜400 nm 之輻射能照射至地球表面。短波長低於175 nm之紫外光線 約在1〇〇公里緯度層會被氧吸收,而輻射介於175 11111至29〇 nm之紫外線約在海平面上15公里處會被臭氧層吸收。眾所 週知,暴露於紫外線輻射下,不但會傷害皮膚,亦會造成 角膜知傷及視覺上之症狀,也是造成形成白内障的主要原 因之一。因此如何提供足夠視覺保護以對抗紫外線輻射, 降低白内障發病率機會,及保護特殊易受紫外線傷害的人 們,例如經眼睛手術治療之病人或是對光敏感之病人,即 為一亟受注重之問題。 一般而言,添加紫外線吸收劑於隱形眼鏡或是一般眼 鏡組成中’可藉由吸收290 nm至400 nm區域間之紫外線而 使有害的紫外線輻射效應減小,不僅可保護視覺系統並且 可降低白内障發病率機會。至今為止,已有許多種不同類 型之紫外線吸收劑被開發且有效應用於隱形眼鏡或一般眼 鏡組成中,但若要防止在不同使用環境下紫外線吸收劑可 能由鏡片流失之缺點,通常較佳之方法是使鏡片材料與可 5 200934458 聚合型紫外線吸收劑反應接枝或共聚合。例如,美國專利 US4,304,895所揭露使用於隱型眼鏡之可反應型紫外光吸 收劑,如下式:200934458 IX. Description of the Invention: [Technical Field of the Invention] 5 10 15 ❹ 20 The present invention relates to a novel polymerizable water-soluble or alcohol-soluble ultraviolet light absorber. The present invention discloses a novel chemical thereof and a method for producing the same Its application in optical medical materials. [Prior Art] Most of the ultraviolet light in the dawn is irradiated to the surface of the earth with radiant energy having a wavelength between 290 nm and 400 nm. Ultraviolet light with a short wavelength below 175 nm is absorbed by oxygen at about 1 km latitude, while ultraviolet rays with radiation between 175 11111 and 29 〇 nm are absorbed by the ozone layer at about 15 km above sea level. It is well known that exposure to ultraviolet radiation not only damages the skin, but also causes corneal damage and visual symptoms, and is one of the main causes of cataract formation. Therefore, how to provide adequate visual protection against UV radiation, reduce the chance of cataract incidence, and protect people who are particularly vulnerable to UV rays, such as patients undergoing eye surgery or patients sensitive to light, is a matter of concern. . In general, the addition of UV absorbers in contact lenses or general glasses can reduce the harmful effects of UV radiation by absorbing UV light between 290 nm and 400 nm, which not only protects the vision system but also reduces cataracts. Incidence rate opportunities. So far, many different types of UV absorbers have been developed and effectively used in contact lens or general eyeglasses. However, it is generally preferred to prevent the UV absorber from being lost by the lens in different environments. The lens material is grafted or copolymerized with the polymerizable UV absorber of 200934458. For example, U.S. Patent No. 4,304,895, the disclosure of which is incorporated herein by reference in its entire entire entire entire entire disclosure
©5 雖然上述具反應基之二苯曱酮類紫外線吸收劑可參與聚 合’但此類型之紫外線吸收劑穩定性較差。當其應用於鏡 片時,該類型吸收劑抗紫外光性能,常會因鏡片使用期及 儲存期時,慢慢的減弱。同時,上述之紫外線吸收劑是疏 10 水的’在親水性佳的壓克力共聚單體和共聚物中則不溶。 即便這些化合物稍微能溶解於親水共聚單體和共聚物,然 而當共聚物發生水合時,它們傾向於從微相分離狀發生凝 | 聚。此凝聚現象使材料變成霧狀,破壞材料的透明性。 另外’美國專利US4,528,311所揭露之可反應型紫外光 15 吸收劑,如下式:©5 Although the above-mentioned reactive benzophenone-based ultraviolet absorber can participate in polymerization, the UV absorber of this type is less stable. When applied to a lens, the anti-ultraviolet properties of this type of absorbent are often slowly diminished due to the period of use and shelf life of the lens. At the same time, the above-mentioned ultraviolet absorber is water-repellent' insoluble in the hydrophilic acrylic comonomer and copolymer. Even though these compounds are slightly soluble in hydrophilic comonomers and copolymers, when the copolymers hydrate, they tend to condense from microphase separation. This agglomeration causes the material to become foggy, destroying the transparency of the material. In addition, the reactive ultraviolet light absorber disclosed in U.S. Patent No. 4,528,311, the following formula:
200934458 上述苯並三唑類型之紫外線吸收劑是可聚合的,且具較佳 穩定性,但該化合物仍傾向疏水性,疏水特性將導致微相 分離及霧狀現象產生。 而,美國專利US6,036,891所揭露的紫外光吸收劑,使 5 用新化合物2- ( 2’-羥基-5’-羥基乙氧基乙基苯基)-2H-苯並 三0坐(2- ( 2,-hydroxy-55-hydroxyethoxyethylphenyl ) -2H-benzotriazole)與甲基丙嫦醢氣(methacryloyl chloride)進 行反應,產生單S旨(mono-ester)類化合物,如下式:200934458 The above-mentioned benzotriazole type ultraviolet absorber is polymerizable and has good stability, but the compound still tends to be hydrophobic, and the hydrophobic property will cause microphase separation and haze formation. The ultraviolet light absorber disclosed in U.S. Patent No. 6,036,891, makes the use of the new compound 2-( 2'-hydroxy-5'-hydroxyethoxyethylphenyl)-2H-benzotriene (2). - (2,-hydroxy-55-hydroxyethoxyethylphenyl) -2H-benzotriazole reacts with methacryloyl chloride to produce a mono-ester compound, as follows:
10 不過,上述專利說明書中並未提及如何獲得新化合物2-(2’-羥基-5’-羥基乙氧基乙基苯基)-2H-苯並三唑,亦未提供關 鍵原料之合成方法,應是該發明專利一大缺憾,同時所得 反應型紫外光吸收劑,雖較以往所發展之吸收劑提升了親 水性能,但其水溶性仍然偏低。日本專利JP3655061中所提 ^5 供之紫外光吸收劑,如下式:10 However, the above patent specification does not mention how to obtain the new compound 2-(2'-hydroxy-5'-hydroxyethoxyethylphenyl)-2H-benzotriazole, nor does it provide the synthesis of key raw materials. The method should be a major defect of the invention patent, and at the same time, the obtained reactive ultraviolet light absorber has higher hydrophilicity than the absorbent developed by the prior art, but its water solubility is still low. The ultraviolet light absorber provided by Japanese Patent JP3655061 is as follows:
CH2CH2—C_OCH2CH2—0-C 一 c=ch2 o ch3 亦遇到水溶性仍然偏低的問題。 親水性和水溶性或醇溶性是不同的性質,由於製成隱 形眼鏡材料必需有親水性,鏡片才能跟著眼珠移動,而達 7 200934458 到校正視力的功能,且親水性可以增加舒適度。由於隱形 眼鏡或人工水晶體親水性的重要性,所以製造鏡片的原 料,必須要有親水性。在合成後,少量沒有聚合的成分, 必須洗除掉,以保證沒有毒性.一般以來,在製造的程序 5 中,必須用大量的溶劑去洗除剩餘未反應之單體,不但費 時費力,更會增加成本。若使用具水溶性或醇溶性佳的成 分進行反應,不但材料聚合後,不會有霧狀的產生,並且 在洗除剩餘未反應之單體時,沒有揮發性有機物(v〇c) ® 排放及環保問題,亦可減低生產成本。 10 我方發明之新穎性式Π)可聚合型的紫外光吸收劑屬 於雙Sb (di-ester)類化合物,同時具有極佳之水溶性或醇 溶性,與親水性或水溶性佳的單體進行反應,將可穩定的 產出良好透明性佳之共聚合產物。 15CH2CH2—C_OCH2CH2—0-C—c=ch2 o ch3 also suffers from the problem that water solubility is still low. Hydrophilic and water-soluble or alcohol-soluble are different properties. Since the contact lens material must be hydrophilic, the lens can follow the eyeball, and the function of correcting vision can be improved, and hydrophilicity can increase comfort. Due to the importance of the hydrophilicity of contact lenses or artificial crystals, the raw materials for the manufacture of lenses must be hydrophilic. After synthesis, a small amount of non-polymerized components must be washed away to ensure no toxicity. In general, in the manufacturing process 5, a large amount of solvent must be used to wash away the remaining unreacted monomers, which is time consuming and laborious. Will increase costs. If a water-soluble or alcohol-soluble component is used for the reaction, not only will the material be produced after the polymerization, but no volatile organic compounds (v〇c) ® will be emitted when the remaining unreacted monomers are washed away. And environmental issues can also reduce production costs. 10 Our novel invention Π) The polymerizable UV absorber belongs to the class of double Sb (di-ester) compounds, and has excellent water solubility or alcohol solubility, and hydrophilic or water soluble monomers. By carrying out the reaction, it is possible to stably produce a copolymerized product which is excellent in transparency and good in transparency. 15
【發明内容】 本發明提供一種新穎的可聚合型水溶性或醇溶性紫外 光吸收劑,其係如下式(1)所示:SUMMARY OF THE INVENTION The present invention provides a novel polymerizable water-soluble or alcohol-soluble ultraviolet light absorber which is represented by the following formula (1):
.〇-fCH2CH2〇VC-C=CH2 (I) 、氣、溴 或碟 其中,Ri為氫或C^-Cs烷基,r2為氫 I為氫或甲基,且^為3〜12。 本發明亦提供一種共聚物,其係由式(1)所示化合物 與親水性或水溶性單體,進行聚合反應而㈣。如此所得 8 20 200934458 * 之共聚物,具有光學性且為透明聚合物,可用於製造光學 醫藥材料如隱形眼鏡或人工水晶體等等。 【實施方式】 本發明所提供之新穎的可聚合型水溶性紫外光吸收 劑,係如下式(I)所示:.〇-fCH2CH2〇VC-C=CH2 (I), gas, bromine or dish wherein Ri is hydrogen or C^-Cs alkyl, r2 is hydrogen I is hydrogen or methyl, and ^ is 3~12. The present invention also provides a copolymer obtained by polymerizing a compound represented by the formula (1) with a hydrophilic or water-soluble monomer (4). The copolymer thus obtained, 8 20 200934458*, is optically and transparent polymer and can be used in the manufacture of optical medical materials such as contact lenses or artificial crystals and the like. [Embodiment] The novel polymerizable water-soluble ultraviolet light absorber provided by the present invention is represented by the following formula (I):
其中,R!為氫或(VC5烷基,R2為氫、氣、溴、或碘, R3為氫或甲基,且m為3〜12。 10 上述式(I)化合物之製備方法,說明如下。經由如下 式(II)之化合物,Wherein R! is hydrogen or (VC5 alkyl, R2 is hydrogen, gas, bromine or iodine, R3 is hydrogen or methyl, and m is 3 to 12. 10) The preparation method of the compound of the above formula (I) is as follows By a compound of the following formula (II),
HOHO
RiRi
CH2CH2COOH (II) 與式(III)之聚乙二醇(PEG ; polyethylene glycol )進行反應,CH2CH2COOH (II) reacts with polyethylene glycol (PEG; polyethylene glycol) of formula (III),
OH (III) 15 獲得式(IV)化合物,OH (III) 15 to obtain a compound of formula (IV),
HOHO
0-fCH2CH2〇VH 9 (IV) 200934458 再將式(IV)化合物與式(V)之丙烯酸類化合物進行反應,0-fCH2CH2〇VH 9 (IV) 200934458 Further reacting a compound of formula (IV) with an acrylic compound of formula (V),
獲得式(I)之化合物。其中’尺^尺广瓜〜化如上述定義, 而X為3~12。 亦或,上述式(I)化合物之製備方法,也經由如下式 (II)之化合物A compound of formula (I) is obtained. Wherein the ruler is as defined above, and X is 3-12. Or, the method for preparing the compound of the above formula (I) is also via a compound of the following formula (II)
與如下式(VI)之化合物進行反應,Reacting with a compound of the following formula (VI),
(VI) 10 而獲得式⑴之化合物。其中,Ri、R2、R3如上述定義,而n 為3〜12 〇 % •本發明上述式(I)水溶性化合物,同樣具有極佳之醇 岭性(alcohol-soluble),而適合應用在製造親水性佳之隱 形眼鏡或人工水晶體。 15 本發明中式(I)化合物較佳者,舉例如下: HO R,(VI) 10 gives the compound of the formula (1). Wherein, Ri, R2, and R3 are as defined above, and n is 3 to 12% by weight. • The water-soluble compound of the above formula (I) of the present invention also has excellent alcohol-soluble, and is suitable for use in the manufacture. Hydrophilic contact lenses or artificial crystals. 15 The compound of the formula (I) in the present invention is preferably, for example, as follows: HO R,
(I), 200934458 化合物(I)-a : ReH,R2=H,R3=H,m=6-8 ; 化合物(I)-b . Ri=H,R2=H,R3=CH3,m=9-ll ; 化合物(I)-c : R^H,R2=H,R3=CH3,m=5_7 ; 化合物(I)-d : Κ((:Η3)3,R2=H,R3=CH3,m=5-7 ; 5 ❹ 10 15 化合物(I)-e : Κ((:Η3)3,R2=H,R3=CH3,m=3-5。 本發明亦提供一種共聚物’其係由式(I)化合物與親 水性或水溶性單體進行聚合反應而形成。如此所得之親水 性佳且具光學性的透明聚合物,可用於隱形眼鏡或人工水 晶體的製造,並可簡化以後未反應單體的洗除(extraet) 步驟。適當之親水性材料包含所謂的水凝膠(hydr〇gel)或 梦水凝勝(silicone hydrogel)。 本發明式(I)化合物與親水性或水溶性單體所進行之 聚合反應’可藉由任何已知方法進行。其進行之製程與條 件係為-般熟諳此藝者所習知…般依需求可能選擇加入 其它添加劑至欲進行之反應中,適當之添加劑包括但不限 於交聯劑、介面活性劑、稀釋劑、安定劑、光起始劑、染 ❹ 為方便更進一步說明起見 體的說明。 將列舉以下實施例做更具 20 之說明,唯 之人士可輕 除非特別說. ,溫度以攝 本發明接著將參考以下各實施例做更詳 非用以限制本發明之範圍,任何熟悉此項技 易達成之料錢變,均涵蓋在衫圍之内 明’實施例中所使用的百分比皆以重量 氏溫度°c為單位。 11 200934458 實施例 實施例中所提到之化合物結構如下所示:(I), 200934458 Compound (I)-a: ReH, R2=H, R3=H, m=6-8; Compound (I)-b. Ri=H, R2=H, R3=CH3, m=9 -ll; Compound (I)-c: R^H, R2=H, R3=CH3, m=5_7; Compound (I)-d: Κ((:Η3)3, R2=H, R3=CH3,m 5 ❹ 10 15 Compound (I)-e : Κ((:Η3)3, R2=H, R3=CH3, m=3-5. The present invention also provides a copolymer of the formula (I) The compound is formed by polymerization with a hydrophilic or water-soluble monomer. The thus obtained hydrophilic polymer having good transparency and transparency can be used for the manufacture of contact lenses or artificial crystals, and can simplify the subsequent unreacted single. The extra-equivalent step of the body. Suitable hydrophilic materials comprise so-called hydrogels or silicone hydrogels. The compounds of the formula (I) according to the invention and hydrophilic or water-soluble monomers The polymerization carried out can be carried out by any known method. The processes and conditions are carried out in a manner that is familiar to the artist. It is possible to add other additives to the desired reaction as appropriate. Additives include, but are not limited to, crosslinkers , surfactant, diluent, stabilizer, photoinitiator, dyeing ❹ For the convenience of further explanation of the first description of the body. The following examples will be described as more 20, but the person can be light unless otherwise stated. The invention is further described in detail below with reference to the following examples, which are not intended to limit the scope of the invention, and any material changes that are readily available to the skilled artisan are included in the embodiments of the invention. The percentages used are in degrees Celsius °c. 11 200934458 The structure of the compounds mentioned in the examples is as follows:
00
II 0-fCH2CH2〇Vc-c=CH2 (I), 4 化合物(I)-a : Ri=H,R2=H,R3=H,m=6-8 ; 化合物(I)-b : R^H,R2=H,R3=CH3,m=9-ll ; 化合物(I)-c : Ri=H,R2=H,R3=CH3,m=5-7 ; 化合物(I)-d : Ι^=(:((:Η3)3,R2=H,R3=CH3,m=5-7 ; 化合物(I)-e : ,R2=H,R3=CH3,m=3-5。II 0-fCH2CH2〇Vc-c=CH2 (I), 4 Compound (I)-a : Ri=H, R2=H, R3=H, m=6-8; Compound (I)-b : R^H , R2=H, R3=CH3, m=9-ll; Compound (I)-c: Ri=H, R2=H, R3=CH3, m=5-7; Compound (I)-d: Ι^= (:((:Η3)3, R2=H, R3=CH3, m=5-7; Compound (I)-e: , R2=H, R3=CH3, m=3-5.
ch2ch2cooh ( n ) 式(11)-1 : Ι^=Η,R2=H ; 式(11)-2 : Κ((:Η3)3,R2=H ;Ch2ch2cooh ( n ) Formula (11)-1 : Ι^=Η, R2=H ; Formula (11)-2 : Κ((:Η3)3, R2=H ;
〇a}〇H ,n=6-8,購於Aldrich公 15 PEG360MA :〇a}〇H, n=6-8, purchased from Aldrich PR 15 PEG360MA:
,n=5-7,購於 Aldrich 公 12 200934458 ο ΌΗ η=9-11,購於 Aldrich, n=5-7, purchased from Aldrich Public 12 200934458 ο ΌΗ η=9-11, purchased from Aldrich
II h2c=c " PEG526MA : CH3 公司; Η、 PEG200 :II h2c=c " PEG526MA : CH3 Company; Η, PEG200:
、CT /〇Η χ ,χ=3-5,購於Fluka公司 實施例一 5 化合物(I)-a製備 @將20克式(11)-1化合物、26.8克?£〇375人人、2.7克對甲 苯續酸(PTSA ; p-Toluenesulfonic acid)及 100克甲苯置入 1公升四頸反應瓶中;反應瓶中分別裝有温度計及蒸餾除水 裝置。將反應瓶於攪拌加熱器上攪拌加熱至112°C後,於蒸 10 餾除水裝置中收集水份約1毫升後以TLC觀察反應是否完 全,降溫至90°C後,保持溫度下緩慢加入100毫升1N碳酸氫 鈉(NaHC03)水溶液攪拌15分鐘,將混合溶液倒入萃取瓶 中靜置分層,將下層水溶液倒入廢液桶中,再加入100毫升 IN NaHC03水溶液倒入萃取瓶混合後靜置分層,將下層水 ^5 溶液丟棄,收集有機層濃縮得45克粗產物(I)-a。 化合物⑴-a純化 將約300克(樣品的15倍量)的管柱充填物(廠牌: Waters ;規格:preparative C18 125A)與450毫升的曱醇均 勻攪拌混合後,緩緩倒入管柱(廠牌:Pyrex;規格:25G3) 20 中進行充填,待管柱中的充填物緊密壓實後以等量的去離 子水將甲醇置換掉,再繼續以2公升沖堤液(甲醇:水=1 : 1)進行置換後,秤取粗產物⑴-a約20克緩緩倒入管柱中, 13 200934458 5 ❹ 10 15 ❹ 先以約2公升沖堤液(甲醇:水=i :丨)以每瓶2〇〇毫升的 量進行沖提收集後,改用甲醇:水=7 : 3的沖堤液繼續充 &收集並取樣以HPLC進行分析,約收集了 4公升後開始有 純度較高的目標產物出現,並以逆向TLC片(Merck RP-18 hwS)進行沖堤終點判斷,待财…檢測結果完成後進行濃 縮符合產品規格的樣品’即得到一呈現褐色油狀的目標產 品。 化合物(I)-a囷譜 ^NMRCCDCls): δ:11.18(8,1Η),8.26 (S,1H),7.90 (q,2H),7.50 (q,2H), 7.20 (d,1H) ’ 7.12 (d,1H) ’ 6.41 (m,1H),6·15 (% 1H),5.82 (m, 1H) M.25(m,4H) *3.63(m,24H) >2.99(t,2H) * 2.68 (t, 2H)。 實施例二〜四 重複實施例一之合成及純化步驟,進行化合物 化合物(I)-c及化合物(I)-d之製備,使用如表一之原料進行相 關反應。 表一, CT /〇Η χ , χ = 3-5, purchased from Fluka Company Example 1 Preparation of Compound (I)-a @ 20 grams of the compound of formula (11)-1, 26.8 grams? £〇375 per person, 2.7 g of p-Toluenesulfonic acid and 100 g of toluene were placed in a 1 liter four-neck reaction flask; the reaction flask was equipped with a thermometer and a distilled water removal device, respectively. The reaction flask was stirred and heated to 112 ° C on a stirring heater. After collecting about 1 ml of water in a steaming 10 water removal apparatus, the reaction was observed by TLC. After cooling to 90 ° C, the temperature was slowly added. 100 ml of 1N aqueous solution of sodium hydrogencarbonate (NaHC03) was stirred for 15 minutes. The mixed solution was poured into an extraction flask and allowed to stand for separation. The lower aqueous solution was poured into a waste liquid tank, and then 100 ml of IN NaHC03 aqueous solution was added and poured into an extraction flask. The layer was allowed to stand, and the lower layer of water was discarded, and the organic layer was concentrated to give 45 g of crude product (I)-a. Purification of Compound (1)-a Approximately 300 g (15 times the amount of the sample) of the column packing (label: Waters; specification: preparative C18 125A) was uniformly stirred and mixed with 450 ml of decyl alcohol, and then slowly poured into the column. (Position: Pyrex; Specification: 25G3) 20 Filling is carried out. After the filling in the column is compacted, the methanol is replaced with an equal amount of deionized water, and then the dying solution (methanol: water) is continued at 2 liters. =1 : 1) After the replacement, weigh about 20 grams of crude product (1)-a and slowly pour it into the column. 13 200934458 5 ❹ 10 15 ❹ First rushing the bank with about 2 liters (methanol: water = i: 丨After scouring and collecting in an amount of 2 ml per bottle, the dyke solution of methanol: water = 7:3 was used to continue charging & collected and sampled for analysis by HPLC, and about 4 liters were collected and purity was started. The higher target product appeared, and the reverse TLC sheet (Merck RP-18 hwS) was used to judge the end point of the embankment. After the test result was completed, the sample which was concentrated to meet the product specifications was obtained, that is, a target product with a brown oil shape was obtained. . Compound (I)-a 囷 spectrum ^NMRCCDCls): δ: 11.18 (8,1 Η), 8.26 (S, 1H), 7.90 (q, 2H), 7.50 (q, 2H), 7.20 (d, 1H) ' 7.12 (d,1H) ' 6.41 (m,1H),6·15 (% 1H),5.82 (m, 1H) M.25(m,4H) *3.63(m,24H) >2.99(t,2H) * 2.68 (t, 2H). Examples 2 to 4 The synthesis and purification steps of Example 1 were repeated, and the preparation of the compound (I)-c and the compound (I)-d was carried out, and the relevant materials were reacted using the materials shown in Table 1. Table I
製備成品 原料一 原料二 實施例二 化合物⑴-b (ΪΪΗ PEG526MA 實施例三 化合物⑴-C aipr— PEG360MA 實施例四 化合物⑴-d (ΪΙΓ2~~ PEG360MA 20 200934458 所得成品化合物(I)-b、化合物(I)-c、及化合物(I)-d相 關1H NMR圖譜如下。 化合物(I)-b圖譜 !H NMR ( CDC13): 5 δ : 11.19 ( s, 1H),8.26(s,lH),7.93(q,2H), 7.52( q,2H),7.21 ( d,1H),7.12( d,1H),6.12( s,1H), 5.56 (s,lH) > 4.26 ( m, 4H ),3.63(m,36H),3.00(t, 2H),2.69 ( t,2H),1.94 ( s,3H)。 φ 化合物(I)-c圖譜 10 XH NMR ( CDCI3): δ : 11.17 ( s,1H),8.24(s,lH),7.91(q,2H), 7.47( q,2H),7.20( d,1H),7.11 ( d,1H),6.12( s,1H), 5.56 (s,lH),4.26(m,4H),3.63(m,20H),3.〇〇 ( t, 2H),2.69 ( t,2H) ,1.89 ( s,3H)。 15 化合物(I)-d圖譜 !H NMR ( CDCI3): δ : 11.81 ( s,1H) ,8.14(s,lH) ,7.92(q,2H), o ^ 7.47( q,2H),7.20( s,1H),6.12( s,1H),5.57( s,1H), 4.28 (m,4H),3.64(m,20H),3.00(t,2H),2.73 ( t, 2〇 2H) ,1.94(s, 3H) ,1.50(s,9H)。 實施例五 化合物(I)-e之製備 將100克式(11)-2化合物、590克PEG200、5·6克對甲笨 25 續酸(PTSA )及500毫升甲苯置入1公升四頸反應瓶中;反 15 200934458 應瓶中分別裝有溫度計及蒸餾除水裝置。將反應瓶於攪拌 加熱器上攪拌加熱至112°C後,於蒸餾除水裝置中收集水份 約5毫升後以TLC觀察反應是否完全,降溫至90°C後,保持 溫度下緩慢加入468毫升水溶液攪拌15分鐘,將混合溶液倒 5 入萃取瓶中靜置分層,將下層水溶液倒入廢液桶中,再加 入400毫升水溶液倒入萃取瓶混合後靜置分層,將下層水溶 液丟棄,收集有機層濃縮得162克產物。 將28.8克上述產物、8.8克曱基丙稀酸(Methacrylic 0 acid.)、0.98克對甲苯磺酸(PTSA)及200 ml甲笨置入1公 10 升四頸反應瓶中;反應瓶中分別裝有溫度計及蒸餾除水裝 置。將反應瓶於攪拌加熱器上攪拌加熱至112°C後,於蒸餾 除水裝置中收集水份約0.8毫升後以TLC觀察反應是否完 全,待反應完全後,降溫至90°C後,保持溫度下緩慢加入 200毫升1N碳酸氫鈉(NaHC03)水溶液攪拌15分鐘,將混 15 合溶液倒入萃取瓶中靜置分層,將下層水溶液倒入廢液桶 中,再加入200毫升1N碳酸氫鈉水溶液倒入萃取瓶混合後靜 置分層,將下層水溶液丟棄,收集有機層濃縮得18克粗產 ®物(I)-e產物。 化合物(I)-e之純化 20 將約225克(樣品的15倍量)的管柱充填物(廠牌:Preparation of raw material and raw material 2 Example 2 Compound (1)-b (ΪΪΗ PEG526MA Example 3 Compound (1)-C aipr-PEG360MA Example 4 Compound (1)-d (ΪΙΓ2~~ PEG360MA 20 200934458 The obtained finished compound (I)-b, compound (I)-c, and the compound (I)-d related 1H NMR spectrum are as follows. Compound (I)-b map! H NMR (CDC13): 5 δ : 11.19 ( s, 1H), 8.26 (s, lH), 7.93(q,2H), 7.52( q,2H), 7.21 ( d,1H), 7.12( d,1H), 6.12( s,1H), 5.56 (s,lH) > 4.26 ( m, 4H ), 3.63 (m, 36H), 3.00 (t, 2H), 2.69 (t, 2H), 1.94 (s, 3H) φ Compound (I)-c spectrum 10 XH NMR (CDCI3): δ: 11.17 ( s, 1H ), 8.24 (s, lH), 7.91 (q, 2H), 7.47 (q, 2H), 7.20 (d, 1H), 7.11 (d, 1H), 6.12 (s, 1H), 5.56 (s, lH) , 4.26 (m, 4H), 3.63 (m, 20H), 3. 〇〇 (t, 2H), 2.69 (t, 2H), 1.89 (s, 3H). 15 Compound (I)-d map! H NMR (CDCI3): δ : 11.81 ( s, 1H) , 8.14 (s, lH) , 7.92 (q, 2H), o ^ 7.47 ( q, 2H), 7.20 ( s, 1H), 6.12 ( s, 1H), 5.57( s,1H), 4.28 (m 4H), 3.64 (m, 20H), 3.00 (t, 2H), 2.73 (t, 2 〇 2H), 1.94 (s, 3H), 1.50 (s, 9H). Example 5 Compound (I)-e Preparation 100 grams of the compound of formula (11)-2, 590 grams of PEG200, 5.6 grams of p-butanol acid (PTSA) and 500 ml of toluene were placed in a 1 liter four-neck reaction flask; The thermometer and the distillation water removal device were installed. The reaction flask was stirred and heated to 112 ° C on a stirring heater, and about 5 ml of water was collected in a distillation water removal device, and the reaction was completely observed by TLC, and the temperature was lowered to 90 ° C. After that, slowly add 468 ml of aqueous solution at a constant temperature for 15 minutes, pour the mixed solution into the extraction flask and let it stand. Pour the lower aqueous solution into the waste liquid tank, and then add 400 ml of the aqueous solution and pour it into the extraction bottle. The layers were separated, the lower aqueous solution was discarded, and the organic layer was concentrated to give 162 g. 28.8 g of the above product, 8.8 g of Methacrylic 0 acid., 0.98 g of p-toluenesulfonic acid (PTSA) and 200 ml of stupid were placed in a 1 liter, four-liter four-neck reaction flask; It is equipped with a thermometer and a distilled water removal device. After the reaction flask was stirred and heated to 112 ° C on a stirring heater, the water was collected in a distillation water removal device to obtain about 0.8 ml of water, and the reaction was observed by TLC. After the reaction was completed, the temperature was lowered to 90 ° C, and the temperature was maintained. Slowly add 200 ml of 1N aqueous solution of sodium bicarbonate (NaHC03) and stir for 15 minutes. Pour the mixed solution into the extraction flask and let it stand. Pour the lower aqueous solution into the waste tank, then add 200 ml of 1N sodium bicarbonate. The aqueous solution was poured into an extraction flask and allowed to stand for separation. The lower aqueous solution was discarded, and the organic layer was collected to give 18 g of crude product (I)-e. Purification of Compound (I)-e 20 Approximately 225 grams (15 times the amount of sample) of the column packing (label:
Waters ;規格:preparative C18 125A )與 225 毫升的曱醇均 勻攪拌混合後,緩緩倒入管柱(廠牌:Pyrex ;規格:25G3) 中進行充填,待管柱中的充填物緊密壓實後以等量的去離 子水將甲醇置換掉,再繼續以1公升甲醇:水=9 : 1的沖堤 16 200934458 液進行置換後’科取粗產物(I)-e約17克緩緩倒入管柱中, 先以約1公升甲醇:水=9 : 1的沖堤液以每瓶200毫升的量 進行沖提收集後,改以每瓶1〇〇毫升繼續沖提收集並取樣以 HPLC進行分析’約收集了 2公升後開始有純度較高的目標 5 產物出現,並以逆向TLC片(Merck RP-18 F254S)進行沖堤 終點判斷’待HPLC檢測結果完成後進行濃縮符合產品規格 的樣品’即得到一呈現褐色油狀的目標產品。 化合物(I)-e 4 NMR圖譜 Q !H NMR ( CDC13): 10 δ : U.81 ( s,1H) ’ 8.14 ( s,1H),7.92 ( q,2H), 7.47(q,2H),7_20(s,1H),6.11( s,1H),5.56( s,1H), 4.26 ( m, 4H),3.63 ( m,12H),3.00 ( t,2H),2.74 ( t, 2H),1.93 ( s, 3H),1.50 ( s,9H)。 15 實施例六 溶解度試驗 實驗中使用市售Benzotriazole A【苯丙酸,3- ( 2H-苯並 ® 二0坐-2-基)-5- (1,1-二曱基乙基)-4-經基-,2-[ ( 2-甲基-1_ 鼓基-2·丙稀基)氧基]乙基酯;Benzenepropanoic acid, 3-20 ( 2H-benzotriazol-2-yl )-5-( 1,1-dimethylethyl )-4-hydroxy-, 2-[(2-methyl-l-oxo-2-propenyl) oxy]ethylester】與化合物 (I)-a、化合物(I)-b、化合物(I)-c、化合物⑴_(i及化合物(i)_e, 以40%異丙醇(IPA ) /60%水之醇水系統進行溶解度測試。 測試方法 17 200934458 在40%異丙醇(IPA)水溶液下之溶解度測定,其儀器 組件如下所示:Waters 717autersampler,Waters 996 PDA (photodiode array detecter),Waters 600 pump,設定注射 量為 20//L,分析管柱:phenamex Luna Cl 8,流速 lmL/min, 5 移動相為氰曱烷。在檢量線製作上,將樣品配製為1023 mg/L之40%IPA水溶液,並以序列稀釋方式稀釋為512.5 mg/L、102.5 mg/L經HPLC分析後,以面積對濃度作圖得檢 量線,樣品在40%IPA水溶液下之溶解度測定上,首先將樣 g 品在室溫下以40%IPA配製為飽和溶液,再將樣品稀釋,使 10 其分析結果之吸收峰面積可在檢量範圍内,以檢量線回推 其真實濃度。結果如圖1所示。 由圖1可知,以40%IPA/60%水之醇水系統進行溶解度 試驗,其結果顯示本發明化合物(I)-a、化合物(I)-b、化合 物(I)-c、化合物(I)-d及化合物(I)-e之溶解度測試,皆優於目 15 前市售產品 Benzotriazole A。 實施例七 〇 應用實驗 實驗中所用之原料及組成用量百分比如表二: 20 表一* 配方 HEMA EGDMA 1907 ΤΡΟ RUVA 1 97.3 1.98 0.33 0.17 2 97.3 1.98 0.33 0.17 0.5 HEMA :甲基丙婦酸 2·經基乙基醋(2,hyHroxyethyl methacrylate) EGDMA :二甲基丙稀酸乙二醇醋(ethylene glycol dimethacrylate) 1907 : Irgacure 907 構於 Ciba 公司 18 200934458 ΤΡΟ : Darocur TPO 購於 Ciba 公司 RUVA :化合物(I)-eWaters;Specification: preparative C18 125A) After mixing with 225 ml of sterol, mix slowly and slowly into the column (label: Pyrex; size: 25G3) for filling, after the packed material in the column is compacted The methanol was replaced with an equal amount of deionized water, and then replaced with 1 liter of methanol: water = 9:1 dyke 16 200934458 liquid, then the crude product (I)-e was slowly poured into about 17 grams. In the column, the levee solution of about 1 liter of methanol:water=9:1 is firstly collected and collected in an amount of 200 ml per bottle. Then, 1 liter of each bottle is continuously extracted and collected and sampled by HPLC. Analysis: After about 2 liters of collection, the target product with higher purity began to appear, and the reverse TLC sheet (Merck RP-18 F254S) was used to judge the end point of the bank. After the HPLC test result was completed, the sample was concentrated to meet the product specifications. 'I get a target product that looks like a brown oil. Compound (I)-e 4 NMR spectrum Q !H NMR (CDC13): 10 δ : U.81 ( s, 1H) ' 8.14 ( s, 1H), 7.92 ( q, 2H), 7.47 (q, 2H), 7_20(s,1H), 6.11( s,1H), 5.56( s,1H), 4.26 ( m, 4H), 3.63 ( m,12H), 3.00 ( t,2H), 2.74 ( t, 2H), 1.93 ( s, 3H), 1.50 ( s, 9H). 15 Example 6 Solubility test Commercially available Benzotriazole A [phenylpropionic acid, 3-( 2H-benzox 2 oxa-2-yl)-5-(1,1-didecylethyl)-4 was used in the experiment. -trans-based, 2-[(2-methyl-1_drum-2-ylpropanyl)oxy]ethyl ester; Benzenepropanoic acid, 3-20 ( 2H-benzotriazol-2-yl )-5-( 1,1-dimethylethyl )-4-hydroxy-, 2-[(2-methyl-l-oxo-2-propenyl) oxy]ethylester] with compound (I)-a, compound (I)-b, compound (I -c, compound (1)_(i and compound (i)_e, solubility test with 40% isopropanol (IPA) / 60% water alcohol water system. Test method 17 200934458 in 40% isopropanol (IPA) aqueous solution For the solubility measurement, the instrument components are as follows: Waters 717autersampler, Waters 996 PDA (photodiode array detecter), Waters 600 pump, set injection volume 20//L, analytical column: phenamex Luna Cl 8, flow rate lmL/min , 5 The mobile phase is cyanocane. In the calibration line production, the sample was prepared as a 1023 mg/L 40% IPA aqueous solution and diluted to 512.5 mg/L and 102.5 mg/L by serial dilution. With area to concentration To determine the solubility of the sample under the 40% IPA aqueous solution, firstly prepare the sample to be a saturated solution at 40% IPA at room temperature, and then dilute the sample to make the absorption peak area of the analysis result of 10 Within the calibration range, the true concentration was pushed back by the calibration curve. The results are shown in Fig. 1. As shown in Fig. 1, the solubility test was carried out with a 40% IPA/60% water alcohol water system, and the results showed the compound of the present invention. The solubility tests of (I)-a, compound (I)-b, compound (I)-c, compound (I)-d and compound (I)-e were all superior to those of Benzotriazole A, which was previously marketed. Example 7 The percentage of raw materials and composition used in the experimental experiment is shown in Table 2: 20 Table 1 * Formulation HEMA EGDMA 1907 ΤΡΟ RUVA 1 97.3 1.98 0.33 0.17 2 97.3 1.98 0.33 0.17 0.5 HEMA : methyl procyanoic acid 2. Ethyl vinegar (2,hyHroxyethyl methacrylate) EGDMA : ethylene glycol dimethacrylate 1907 : Irgacure 907 in Ciba company 18 200934458 ΤΡΟ : Darocur TPO purchased from Ciba company RUVA : compound (I) -e
以表二列舉該可聚合混合物之各組成份比例,合成水 凝膠(hydrogel )的薄膜,薄膜厚度(thickness )約為0.18 mm 到0.20 mm間。薄膜之穿透率圖譜 (transmission spectrum) 可用紫外線光譜儀(UV spectrophotomer)測定之,而各紫 外線圖譜(UV sepctrum ),詳如圖2所示。其中,實線(一) 為配方1 *虛線(—)為配方2。在應用實驗結果中,糟由 紫外線穿透圖譜顯示,本發明新穎可聚合水溶性或醇溶性 紫外光吸收劑單體應用於隱形眼鏡中有極佳之紫外光遮蔽 效果。 綜上所述,本發明確能藉所揭露之技術思想以達到發 明目的,具新穎性、進步性與可供產業利用性,並與發明 15 專利要件相符合。惟以上所揭示者,乃較佳實施例,舉凡 局部之變更或修飾而源於本案之技術思想而為熟悉該項技 術之人士所易於推知者,倶不脫本案之專利權範圍。 上述實施例僅係為了方便說明而舉例而已,本發明所 Ο 主張之權利範圍自應以申請專利範圍所述為準,而非僅限 20 於上述實施例。 【圖式簡單說明】 圖1係本發明實施例六中,市售Benzotriazole A與本發明化 合物(I)-a、化合物(I)-b、化合物(I)-c、化合物(I:)-d及化合物 25 (I)-e解度測試之結果。 19 200934458 # 圖2係本發明實施例七中,不含本發明化合物之配方1,以 及含本發明化合物(I)-e之配方2,兩者之紫外線穿透圖譜。 【主要元件符號說明】 5 無 〇 20A hydrogel film was synthesized in the ratio of the respective components of the polymerizable mixture in Table 2. The film thickness was between 0.18 mm and 0.20 mm. The transmission spectrum of the film can be measured by a UV spectrophotomer, and each UV map (UV sepctrum) is shown in Fig. 2. Among them, the solid line (1) is the formula 1 * the dotted line (-) is the formula 2. In the application experiment results, the ultraviolet-transmission map of the present invention shows that the novel polymerizable water-soluble or alcohol-soluble ultraviolet light absorber monomer of the present invention has excellent ultraviolet light shielding effect in contact lenses. In summary, the present invention can indeed achieve the purpose of the invention through the disclosed technical ideas, and is novel, progressive and available for industrial use, and is in conformity with the patent requirements of the invention 15 . It is to be understood that the above-described embodiments, which are susceptible to variations and modifications, are derived from the technical idea of the present invention and are readily inferred by those skilled in the art. The above-described embodiments are merely examples for the convenience of the description, and the scope of the claims is intended to be limited to the above embodiments. BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 is a commercially available Benzotriazole A and a compound (I)-a, a compound (I)-b, a compound (I)-c, and a compound (I:) in the sixth embodiment of the present invention. d and the results of the compound 25 (I)-e resolution test. 19 200934458 # Figure 2 is a UV-transfer map of Formulation 1 containing no compound of the present invention, and Formulation 2 containing Compound (I)-e of the present invention, in Example 7 of the present invention. [Main component symbol description] 5 None 〇 20
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW97104292A TWI381829B (en) | 2008-02-04 | 2008-02-04 | Polymerizable water-soluble or alcohol-soluble uv-light absorbent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW97104292A TWI381829B (en) | 2008-02-04 | 2008-02-04 | Polymerizable water-soluble or alcohol-soluble uv-light absorbent |
Publications (2)
Publication Number | Publication Date |
---|---|
TW200934458A true TW200934458A (en) | 2009-08-16 |
TWI381829B TWI381829B (en) | 2013-01-11 |
Family
ID=44866278
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW97104292A TWI381829B (en) | 2008-02-04 | 2008-02-04 | Polymerizable water-soluble or alcohol-soluble uv-light absorbent |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI381829B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104910085A (en) * | 2014-03-10 | 2015-09-16 | 中日合成化学股份有限公司 | Liquid reaction type ultraviolet absorbent and its preparation method and application |
TWI718257B (en) * | 2016-02-22 | 2021-02-11 | 瑞士商愛爾康公司 | Uv-absorbing vinylic monomers and uses thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3655061B2 (en) * | 1997-07-31 | 2005-06-02 | 株式会社ニデック | UV-absorbing substrate |
JP2002226521A (en) * | 2001-02-02 | 2002-08-14 | Otsuka Chem Co Ltd | Ultraviolet absorbing copolymer |
-
2008
- 2008-02-04 TW TW97104292A patent/TWI381829B/en not_active IP Right Cessation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104910085A (en) * | 2014-03-10 | 2015-09-16 | 中日合成化学股份有限公司 | Liquid reaction type ultraviolet absorbent and its preparation method and application |
CN104910085B (en) * | 2014-03-10 | 2018-07-10 | 中日合成化学股份有限公司 | Liquid reaction type ultraviolet absorbent and its preparation method and application |
TWI718257B (en) * | 2016-02-22 | 2021-02-11 | 瑞士商愛爾康公司 | Uv-absorbing vinylic monomers and uses thereof |
Also Published As
Publication number | Publication date |
---|---|
TWI381829B (en) | 2013-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5732455B2 (en) | UV / Visible light absorbers for ophthalmic lens materials | |
JP2807217B2 (en) | UV absorbing composition | |
JP5758407B2 (en) | Visible light absorbers for ophthalmic lens materials | |
JP5732456B2 (en) | Visible light absorbers for ophthalmic lens materials | |
JP5324575B2 (en) | Ophthalmic lens material comprising a chromophore that absorbs both UV light and short wavelength visible light | |
JP2685980B2 (en) | UV absorbing intraocular lens | |
CN1223586C (en) | Pigment for intra-ocular lens and intra-ocular lens using said pigment | |
AU2015247438B2 (en) | (meth)acrylamide polymers for contact lens and intraocular lens | |
JP2010535906A (en) | Ophthalmic lens material comprising a chromophore that absorbs both UV light and short wavelength visible light | |
US11642217B2 (en) | Intraocular lens compositions | |
EP1931621B1 (en) | Compounds suitable as polymerizable yellow dyes; polymerizable and/or crosslinkable compositions, polymer matrices and intraocular lenses containing same | |
JP2000007735A (en) | Ultraviolet-absorbing material | |
TW200934458A (en) | Polymerizable water-soluble or alcohol-soluble UV-light absorbent | |
JPH10195324A (en) | Yellow reactive dye and spectacle lens containing the same | |
US7915322B2 (en) | Polymerizable water-soluble or alcohol-soluble ultraviolet absorber | |
CN110382628B (en) | Polymerizable dye compound, preparation method, polymer containing dye and application | |
WO2015022511A1 (en) | Monomers for use in a polymerizable composition and high refractive index polymer for opthalmic applications | |
JP2019056086A (en) | Gel composition | |
JP2010088858A (en) | Medical material | |
JP3727035B2 (en) | Benzotriazole compound, ultraviolet absorber comprising the same, and ophthalmic lens containing the same | |
JPH09235309A (en) | Lens material for eye containing ultraviolet ray-absorbing polymer not having polymerizable group and its production | |
JP3195423B2 (en) | Intraocular lens material | |
JP2010032992A (en) | Ophthalmic lens | |
WO1992020721A1 (en) | Process for producing both of ultraviolet-absorbent self-dispersible water-base vinyl resin and fine resin particle | |
JP6265684B2 (en) | Polymerizable UV absorbing dye for intraocular lens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |